Amicus Therapeutics, Inc. (FOLD) Live Share Price, Invest From India

Amicus Therapeutics, Inc. Stock Performance

as on April 25, 2026 at 6:59 am IST

Day's High
$14.49
Day's Price Range
$14.50
$14.49
0.07%
Upside
52 Week's Low
52 Week's High
$5.51
52-Week Price Range
$14.50
$14.49
61.97%
Downside
0.07%
Upside

Amicus Therapeutics, Inc. share price movements today

Previous Close: $14.46
Open: $14.49
Volume: 3.4M
Day's Low - High: $14.49 - $14.50
52 Week Low - High: $5.51 - $14.50

Amicus Therapeutics, Inc. Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Amicus Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Amicus Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Amicus Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amicus Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Amicus Therapeutics, Inc.	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	110.54%	77.57	12.55%
Vertex Pharmaceuticals Inc	BUY	$108.7B	94.28%	27.93	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.49	5.37%
Regeneron Pharmaceuticals Inc	BUY	$74.1B	45.73%	17.27	29.65%

Analyst Recommendation on Amicus Therapeutics, Inc. Stock

Based on 17 analysts

BUY

76.47%

Buy

23.53%

Hold

0.00%

Sell

Based on 17 analysts, 76.47% of analysts recommend a 'BUY' rating for Amicus Therapeutics, Inc.. Average target price of $14.5

Amicus Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Amicus Therapeutics, Inc..

What analysts predicted

0.07%UPSIDE

Target Price

$14.5

Current Price

$14.49

Analyzed by

17 Analysts

Target

$14.50

Amicus Therapeutics, Inc. target price $14.5, a slight upside of 0.07% compared to current price of $14.49. According to 17 analysts rating.

Amicus Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	103	115	110	126	141	149	125	154	169	185
Gross Profit	93	103	96	115	128	134	113	139	147	156
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-21	-33	-48	-15	-6	14	-21	-24	17	1
Net Profit Margin	-20.85%	-29.41%	-43.86%	-12.39%	-4.75%	9.85%	-17.31%	-15.79%	10.24%	0.91%

Amicus Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	4	36	91	182	260	305	329	399	528	634
Gross Profit	4	30	76	160	229	271	290	362	475	553
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-200	-284	-348	-356	-276	-250	-236	-151	-56	-27
Net Profit Margin	-4034.73%	-769.03%	-382.48%	-195.56%	-106.12%	-81.98%	-71.85%	-37.96%	-10.62%	-4.27%

Global Institutional Holdings in Amicus Therapeutics, Inc.

Funds	Holdings
Balyasny Asset Management LLC	1.63%
Macquarie Group Ltd	1.45%
Citadel Advisors Llc	2.63%
Magnetar Financial LLC	1.26%
Geode Capital Management, LLC	2.34%

See all

Amicus Therapeutics, Inc. News & Key Events

Insights on Amicus Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, FOLD has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 6 months, FOLD stock has moved up by 63.5%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 125.24M → 185.21M (in $), with an average increase of 12.1% per quarter
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, FOLD has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 17.30M → 1.69M (in $), with an average decrease of 90.2% per quarter

About Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. is a global biotechnology company focused on discovering, developing and delivering medicines for people living with rare diseases. Its two marketed therapies are Galafold, the first oral monotherapy for people living with Fabry disease who have amenable genetic variants, and Pombiliti + Opfolda, a two-component treatment for adults living with late-onset Pompe disease. As an orally miglustat monotherapy, Galafold is designed to bind to and stabilize an endogenous alpha-galactosidase A enzyme in those patients with genetic variants identified as amenable in a Good Laboratory Practice cell-based amenability assay. Pombiliti + Opfolda consists of an engineered rhGAA enzyme, cipaglucosidase alfa-atga, with an optimized carbohydrate structure to enhance cellular uptake, administered intravenously in combination with orally administered miglustat. In addition, clinical studies are ongoing in pediatric patients for both the LOPD and IOPD populations.

Organisation	Amicus Therapeutics, Inc.
E-voting on shares	Click here to vote

FAQs

What is Amicus Therapeutics, Inc. share price today?

Amicus Therapeutics, Inc. share price today is $14.49 as on April 25, 2026 at 1:29 am IST at the close of the market. Amicus Therapeutics, Inc. share today touched a day high of $14.5 and a low of $14.49.

What is the 52 week high and 52 week low for Amicus Therapeutics, Inc. share?

Amicus Therapeutics, Inc. share touched a 52 week high of $14.5 on April 24, 2026 and a 52 week low of $5.51 on June 25, 2025. Amicus Therapeutics, Inc. stock price today i.e. April 25, 2026 at 1:29 am IST is closed at $14.49,which is 0.07% down from its 52 week high and 162.98% up from its 52 week low.

How to invest in Amicus Therapeutics, Inc. Stock (FOLD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Amicus Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amicus Therapeutics, Inc. Shares that will get you 0.1035 shares as per Amicus Therapeutics, Inc. share price of $14.49 per share as on April 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Amicus Therapeutics, Inc. Stock (FOLD) from India?

Indian investors can start investing in Amicus Therapeutics, Inc. (FOLD) shares with as little as ₹94.91 or $1 (as of May 4, 2026 at 8:34 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Amicus Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on May 4, 2026 at 8:34 am IST). Based on Amicus Therapeutics, Inc. share’s latest price of $14.49 as on April 25, 2026 at 1:29 am IST, you will get 0.6901 shares of Amicus Therapeutics, Inc.. Learn more about fractional shares .